Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy

Neuroscience Letters

Volumn 504, Issue 3, 2011, Pages 185-190

  Taniguchi, Hidetoshi ^a   Anacker, Christoph ^a   Suarez Mier, Gabriela Beatriz ^a   Wang, Qian ^a   Andreasson, Katrin ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

EP1 4 receptors; G protein coupled receptors; Hypoxic ischemic encephalopathy; Misoprostol; PGE2

Indexed keywords

MISOPROSTOL; PROSTAGLANDIN E RECEPTOR 1; PROSTAGLANDIN E RECEPTOR 2; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; GLUCOSE; HYDRAZINE DERIVATIVE; OXAZEPINE DERIVATIVE; OXYGEN; PROSTAGLANDIN E2; SC 51089;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL PROTECTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FOREBRAIN; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INTRACELLULAR SIGNALING; MALE; NERVE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN MODIFICATION; RAT; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HIPPOCAMPUS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; DINOPROSTONE; ENDOTHELIAL CELLS; GLUCOSE; HIPPOCAMPUS; HYDRAZINES; HYPOXIA-ISCHEMIA, BRAIN; MISOPROSTOL; NEURONS; OXAZEPINES; OXYGEN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E, EP1 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP2 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP3 SUBTYPE; RECEPTORS, PROSTAGLANDIN E, EP4 SUBTYPE; SIGNAL TRANSDUCTION;

EID: 82455171895     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.09.005     Document Type: Article

References (27)

1. 2 EP1 receptor inhibition has a wide therapeutic window, is sustained in time and is not sexually dimorphic. J. Cereb. Blood Flow Metab. 2009, 29:66-72.
2. Ahmad A.S., Saleem S., Ahmad M., Dore S. Prostaglandin EP1 receptor contributes to excitotoxicity and focal ischemic brain damage. Toxicol. Sci. 2006, 89:265-270.
3. Andreasson K. Prostaglandin signalling in cerebral ischaemia. Br. J. Pharmacol. 2010, 160:844-846.
4. 2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis. Ann. Neurol. 2004, 56:240-248.
5. Breyer R.M., Bagdassarian C.K., Myers S.A., Breyer M.D. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 2001, 41:661-690.
6. Breyer R.M., Davis L.S., Nian C., Redha R., Stillman B., Jacobson H.R., Breyer M.D. Cloning and expression of the rabbit prostaglandin EP4 receptor. Am. J. Physiol. 1996, 270:F485-F493.
7. Fedyk E.R., Ripper J.M., Brown D.M., Phipps R.P. A molecular analysis of PGE receptor (EP) expression on normal and tranformed B lyphocytes: coexpression of EP1, EP2, EP3beta and EP4. Mol. Immunol. 1996, 33:33-45.
8. Hewett S.J., Bell S.C., Hewett J.A. Contributions of cyclooxygenase-2 to neuroplasticity and neuropathology of the central nervous system. Pharmacol. Ther. 2006, 112:335-357.
9. 2 EP1 receptors: downstream effectors of COX-2 neurotoxicity. Nat. Med. 2006, 12:225-229.
10. Li H., Pin S., Zeng Z., Wang M.M., Andreasson K.A., McCullough L.D. Sex differences in cell death. Ann. Neurol. 2005, 58:317-321.
11. Li J., Liang X., Wang Q., Breyer R.M., McCullough L., Andreasson K. Misoprostol, an anti-ulcer agent and PGE(2) receptor agonist, protects against cerebral ischemia. Neurosci. Lett. 2008, 438:210-215.
12. 2 mediates neuronal protection via the DP1 receptor. J. Neurochem. 2005, 92:477-486.
13. 2 EP2 receptor in permanent focal cerebral ischemia. Ann. Neurol. 2005, 57:758-761.
14. 2 EP2 receptor in cerebral ischemia. J. Neurosci. 2004, 24:257-268.
15. Nogawa S., Zhang F., Ross M.E., Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 1997, 17:2746-2755.
16. Reimer R., Heim H.K., Muallem R., Odes H.S., Sewing K.F. Effects of EP-receptor subtype specific agonists and other prostanoids on adenylate cyclase activity of duodenal epithelial cells. Prostaglandins 1992, 44:485-493.
17. Rice J.E., Vannucci R.C., Brierley J.B. The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 1981, 9:131-141.
18. Riezzo I., Neri M., De Stefano F., Fulcheri E., Ventura F., Pomara C., Rabozzi R., Turillazzi E., Fineschi V. The timing of perinatal hypoxia/ischemia events in term neonates: a retrospective autopsy study. HSPs, ORP-150 and COX2 are reliable markers to classify acute, perinatal events. Diagn. Pathol. 2010, 5:49.
19. Saleem S., Li R.C., Wei G., Dore S. Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice. J. Neurosci. Res. 2007, 85:2433-2440.
20. Siegel C., Turtzo C., McCullough L.D. Sex differences in cerebral ischemia: possible molecular mechanisms. J. Neurosci. Res. 2010, 88:2765-2774.
21. Taniguchi H., Andreasson K. The hypoxic-ischemic encephalopathy model of perinatal ischemia. J. Vis. Exp. 2008.
22. 2 protects neonatal mouse brain from hypoxic ischemic injury. J. Neurosci. 2007, 27:4303-4312.
23. Ten V.S., Bradley-Moore M., Gingrich J.A., Stark R.I., Pinsky D.J. Brain injury and neurofunctional deficit in neonatal mice with hypoxic-ischemic encephalopathy. Behav. Brain Res. 2003, 145:209-219.
24. (2) and prostanoid analogs involved in binding and activation of the human EP(1) prostanoid receptor. Mol. Pharmacol. 2001, 59:1446-1456.
25. Wu L., Wang Q., Liang X., Andreasson K. Divergent effects of prostaglandin receptor signaling on neuronal survival. Neurosci. Lett. 2007, 421:253-258.
26. Yamagata K., Andreasson K.I., Kaufmann W.E., Barnes C.A., Worley P.F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron 1993, 11:371-386.
27. 2 receptor EP1 inhibition involves the PTEN/AKT pathway. Neurobiol. Dis. 2008, 29:543-551.